ACADIA Pharmaceuticals Inc. vs CVS Health Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.06B), while CVS Health Corp trades at $93.32 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 24.2× ACADIA Pharmaceuticals Inc.'s market cap, and CVS Health Corp pays a 2.78% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | CVS | |
|---|---|---|
Market Cap | $5.06B | $122.36B |
Sector | Health | Health |
52-Week High | $29.41 | $110.60 |
52-Week Low | $20.06 | $65.51 |
Enterprise Value | $4.18B | $184.71B |
Dividend Yield | — | 2.78% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →